Mersana Therapeutics, Inc. (MRSN) Social Stream
Mersana Therapeutics Inc (MRSN) Price Targets From Analysts
Use the tables below to see what analysts covering Mersana Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
MRSN's average price target has moved down $7 over the prior 15 months.
MRSN reports an average of 170.8% for its upside potential over the past 49 weeks.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MRSN Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
MRSN's average broker recommendation rating improved by 0 over the prior 120 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Mersana Therapeutics Inc's upside potential (average analyst target price relative to current price) is higher than 764.07% of all US stocks.
- In terms of how Mersana Therapeutics Inc fares relative to all US stocks, note that its variance in analysts' estimates is lower than -613% of that group.
- Mersana Therapeutics Inc's number of analysts covering the stock is higher than 690.96% of stocks in the small market cap category.
- MRSN has a greater average analyst price target than 304.98% of Healthcare stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to Mersana Therapeutics Inc are MRNS, MRKR, and MREO.
Make investment decisions regarding MRSN using the data that counts. Try POWR Ratings for free.